VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Trevi Therapeutics, Inc. (TRVI) Total Return Calculator with Dividends Reinvested

Trevi Therapeutics, Inc.

Popular:

The total return for Trevi Therapeutics, Inc. (TRVI) stock is +116.72% over the past 12 months. So far it's up 19.93% this year. The 5-year total return is +595.61%, meaning $10,000 invested in TRVI stock 5 years ago would be worth $69,561 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in TRVI 1 year ago, it would be worth $21,411 today — you'd have gained $11,411.

With Dividends Reinvested$21,411+114.11%

Price Only (No DRIP)$21,411+114.11%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in TRVI

1Y$21,672+$11,672 (+116.7%)116.7% CAGR

3Y$45,270+$35,270 (+352.7%)65.4% CAGR

5Y$69,561+$59,561 (+595.6%)47.4% CAGR

10Y$18,074+$8,074 (+80.7%)6.1% CAGR

15Y$18,073+$8,073 (+80.7%)4.0% CAGR

20Y$18,073+$8,073 (+80.7%)3.0% CAGR

30Y$18,074+$8,074 (+80.7%)2.0% CAGR

Trevi Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading TRVI total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+19.93%	—	+19.93%	—	$11,993
1Y	+116.72%	116.72%	+116.72%	—	$21,672
3Y	+352.70%	65.43%	+352.70%	—	$45,270
5Y	+595.61%	47.39%	+595.61%	—	$69,561
10Y	+80.74%	6.10%	+80.74%	—	$18,074
15Y	+80.73%	4.02%	+80.73%	—	$18,073
20Y	+80.73%	3.00%	+80.73%	—	$18,073
30Y	+80.74%	1.99%	+80.74%	—	$18,074

Risk & Highlights

Best Year+216.92%2024

Worst Year-70.48%2021

Max Drawdown-29.50%2025-12-10 → 2026-01-23 · Recovered 2026-04-15

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+0.25%	+0.25%	—	+0.41%	-0.2pp
2025	+187.16%	+187.16%	—	+16.64%	+170.5pp
2024	+216.92%	+216.92%	—	+24.00%	+192.9pp
2023	-33.99%	-33.99%	—	+24.81%	-58.8pp
2022	+144.30%	+144.30%	—	-19.95%	+164.2pp

TRVI outperformed the S&P 500 by 85.39pp over the past year (+116.72% vs +31.32%).

Loading summary...

TRVI Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
TRVITrevi Therapeutics, Inc.	$2.0B	+11.3%	+19.9%	+116.7%	—	+352.7%	+595.6%	+80.7%
IDYAIDEAYA Biosciences, Inc.	$2.5B	-11.1%	-15.1%	+61.9%	—	+48.0%	+51.3%	+156.8%
PTCTPTC Therapeutics, Inc.	$5.5B	-3.3%	-13.2%	+84.1%	—	+19.9%	+65.2%	+839.5%
ACADACADIA Pharmaceuticals Inc.	$3.7B	-3.8%	-17.9%	+47.7%	—	-0.3%	+2.5%	-22.3%
INVAInnoviva, Inc.	$1.9B	-2.2%	+13.3%	+20.4%	—	+92.8%	+95.5%	+90.5%
PRAXPraxis Precision Medicines, Inc.	$7.6B	+9.0%	+18.0%	+860.9%	—	+2005.6%	-18.4%	-19.0%
NKTRNektar Therapeutics	$1.7B	+13.9%	+96.0%	+783.6%	—	+636.7%	-69.4%	-57.6%
AXSMAxsome Therapeutics, Inc.	$11.5B	+31.2%	+24.6%	+98.5%	—	+186.4%	+295.0%	+1858.0%
CRLCharles River Laboratories International, Inc.	$9.0B	+8.0%	-10.2%	+57.5%	—	-4.3%	-46.0%	+124.7%
IQVIQVIA Holdings Inc.	$29.9B	+3.4%	-21.7%	+20.7%	—	-7.0%	-23.7%	+167.5%
MEDPMedpace Holdings, Inc.	$12.2B	-14.0%	-25.3%	+47.8%	—	+103.7%	+160.4%	+1435.8%

Compare:TRVI vs IDYA TRVI vs PTCT TRVI vs ACAD TRVI vs IDYA vs PTCT

About TRVI Dividend Returns

Trevi Therapeutics, Inc. (TRVI) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of TRVI over the past year?

Trevi Therapeutics, Inc. (TRVI) delivered a return of 116.72% over the past year. Since TRVI does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in TRVI be worth today?

A $10,000 investment in Trevi Therapeutics, Inc. one year ago would be worth $21,672 today, representing a gain of $11,672.

Q3Does TRVI pay dividends?

Trevi Therapeutics, Inc. (TRVI) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For TRVI, the total return equals the price-only return.

Q4Did TRVI beat the S&P 500?

Yes, Trevi Therapeutics, Inc. (TRVI) outperformed the S&P 500 by 85.39 percentage points over the past year. TRVI delivered a total return of 116.72%, compared to the S&P 500's 31.32%. This 85.39pp alpha means investors in TRVI earned more than a passive S&P 500 index fund.

Q5What is TRVI's worst drawdown?

Trevi Therapeutics, Inc. (TRVI) experienced a maximum drawdown of -29.50% over the past year, declining from its peak on 2025-12-10 to its trough on 2026-01-23. The stock recovered to its prior peak by 2026-04-15. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is TRVI's long-term total return over 10, 20, or 30 years?

Here are Trevi Therapeutics, Inc. (TRVI)'s long-term returns with dividends reinvested. Over 10 years, the total return is 80.7% (6.1% CAGR) — $10,000 would have grown to $18,074. Over 20 years: 80.7% total return (3.0% CAGR) — $10,000 → $18,073. Over 30 years: 80.7% total return (2.0% CAGR) — $10,000 → $18,074. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was TRVI's best and worst year?

Trevi Therapeutics, Inc.'s best calendar year was 2024 with a total return of 216.9%. Its worst year was 2021 with a total return of -70.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 287.4 percentage points.